To better understand the evolution of cancer cells and to test drugs, clinicians need samples of healthy or diseased organs. The HCS Pharma teams have developed an approach that enables the ...
REHOVOT, UNITED KINGDOM, August 14, 2023/EINPresswire.com/ -- Poor predictability of animal models is one of the most time and money consuming step in pre-clinical ...
HCS Pharma, a company based in Lille and created in 2013, unveils the successes of the ONCO3D project, aimed at discovering new anti-cancer therapies, in particular for breast cancer (the number one ...
French biotech firm HCS Pharma, will be offering pre-IPO securities via a security token offering on the European Digital Assets Exchange or EDSX. EDSX entered the digital security space earlier this ...
INTEGRA’s VIAFLO 96 electronic multi-channel pipetting system is helping biotechnology company HCS Pharma to improve the reproducibility of high content screening using its patented BIOMIMESYS® 3D ...
HCS Pharma with a current evaluation of €200 mln is a French biotech company that is combining disruptive fintech with traditional economy and finance. HCS Pharma has confirmed that it will get listed ...
3D cell culture systems have recently emerged as tools for reproducing the cellular environment and the organization of tissues/organs, where cells are connected to each other and to the surrounding ...
INTEGRA’s VIAFLO 96 electronic multi-channel pipetting system is helping biotechnology company HCS Pharma to improve the reproducibility of high content screening using its patented BIOMIMESYS ® 3D ...
Vidac Pharma and HCS Pharma Announce cooperative agreement on acceleration of pre-clinical assays for Vidac Pharma anti Solid Tumors drug candidates. Vidac Pharma Holding Plc (XSTU:SYM: T9G; ISIN: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback